Evidence map›Paper›PMID 25535294›Full record

Trial reportTobacco control2015

Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers.

Neal L Benowitz, Quan Gan, Maciej L Goniewicz, Wei Lu, Jiying Xu, Xinjian Li, Peyton Jacob, Stanton Glantz

Registry-linked trialAbstract readClinical TrialComparative Study
In one paragraph

Trial report in Tobacco control, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00264342 (Safety of Nicotine Reduction Strategy), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00264342 completednot on this map

Safety of Nicotine Reduction Strategy

TypeobservationalSponsorUniversity of California, San FranciscoRan2005 to 2010Enrolled135ConditionsNicotine Dependence, Tobacco Use Disorder
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Biomarkers of Exposure to Nicotine and Selected Toxicants in Individuals Who Use Alternative Tobacco Products Sold in Japan and Canada from 2018 to 2019.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  2. Article
  3. Article
  4. Biomarkers of exposure to new and emerging tobacco delivery products.American journal of physiology. Lung cellular and molecular physiology · 2017
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Neal L BenowitzDivision of Clinical Pharmacology and Experimental Therapeutics, Medical Service, Departments of Medicine, and Bioengineering & Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA Center for Tobacco Control Research and Education, University of California San Francisco, San Francisco, California, USA.
Quan GanShanghai Center for Disease Control and Prevention, Shanghai, China.
Maciej L GoniewiczDepartment of Health Behavior, Division of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York, USA.
Wei LuShanghai Center for Disease Control and Prevention, Shanghai, China.
Jiying XuShanghai Center for Disease Control and Prevention, Shanghai, China.
Xinjian LiShanghai Center for Disease Control and Prevention, Shanghai, China.
Peyton JacobDivision of Clinical Pharmacology and Experimental Therapeutics, Medical Service, Departments of Medicine, and Bioengineering & Therapeutic Sciences, University of California San Francisco, San Francisco, California, USA Center for Tobacco Control Research and Education, University of California San Francisco, San Francisco, California, USA.
Stanton GlantzCenter for Tobacco Control Research and Education, University of California San Francisco, San Francisco, California, USA Division of Cardiology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Shanghai Municipal Center For Disease Control Prevention · CNUniversity of California, San Francisco · USCenter for Disease Control · TWRoswell Park Comprehensive Cancer Center · US

Funding

Research Support CoreP30DA012393 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ST.HELEN, GIDEON · 1999 to 2024
$17.1M
Postdoctoral training in tobacco controlR25CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 2006 to 2015
$5.4M
Postdoctoral training in tobacco controlT32CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2016 to 2020
$2.6M
NCI NIH HHS CA-113710NCI NIH HHS R25 CA113710NCI NIH HHS T32 CA113710NIDA NIH HHS DA01293NIDA NIH HHS P30 DA012393
6 · The paper itself

Abstract

backgroundDifferences in carcinogen exposure from different cigarette products could contribute to differences in smoking-associated cancer incidence among Chinese compared with US smokers.

methodsUrine concentrations of metabolites of nicotine, the tobacco-specific nitrosamine (TSNA) 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and polycyclic aromatic hydrocarbon metabolites (PAHs) were compared in 238 Chinese and 203 US daily smokers.

resultsComparing Chinese versus US smokers, daily nicotine intake and nicotine intake per cigarette smoked were found to be similar. When normalised for cigarettes per day, urine NNAL excretion was fourfold higher in US smokers, while the excretion of urine metabolites of the PAHs fluorene, phenanthrene and pyrene metabolites was 50% to fourfold higher in Chinese smokers (all, p<0.0001). Similar results were seen when NNAL and PAHs excretion was normalised for daily nicotine intake.

conclusionsPatterns of carcinogen exposure differ, with lower exposure to TSNA and higher exposure to PAHs in Chinese compared with US smokers. These results most likely reflect country differences in cigarette tobacco blends and manufacturing processes, as well as different environmental exposures. TRIAL REGISTRATION NUMBER: NCT00264342.

Indexed as

AdultBiomarkersCarcinogensChinaConsumer Product SafetyFemaleHumansMaleNitrosaminesPyrenesSmokingUnited States4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneBiomarkersCarcinogensNitrosaminespyrenePyrenesCarcinogensGlobal healthNicotine

Identifiers

PMID25535294
PMCPMC4476967
OpenAlexW2104163317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.